| Financial Year |
March 31 2023 |
| Monetary Funds |
974,616,666.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
18,753,029.64 |
| Accounts Receivable |
1,682,461,286.85 |
| Advances to Suppliers |
471,403,709.67 |
| Other Receivables |
1,034,038,103.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
84,907,051.51 |
| Inventories |
223,700,317.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
132,479,843.91 |
| Other Current Assets |
98,734,187.96 |
| Total Current Assets |
11,253,235,933.70 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,410,991,660.06 |
| Long-term Equity Investment |
2,922,728,830.84 |
| Investment Properties |
429,665,641.85 |
| Fixed Assetes |
279,027,590.67 |
| Under-construction Projects |
15,561,515.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
89,697,905.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,404,041.46 |
| Deferred Income Tax Assets |
311,091,499.30 |
| Other Non-Current Assets |
578,639,165.91 |
| Sub-Total of Non-Current Assets |
7,535,800,480.26 |
| Total Assets |
18,789,036,413.96 |
| Short-Term Loans |
2,761,826,387.68 |
| Trading Financial liabilities |
-- |
| Notes Payable |
82,423,056.25 |
| Accounts Payable |
6,504,598,071.66 |
| Accounts Received In Advance |
1,391,269.27 |
| Employee Compensation Payable |
1,739,304.00 |
| Taxes Payable |
7,752,676.61 |
| Interest Payable |
1,001,095.89 |
| Dividend Payable |
-- |
| Other payables |
408,427,785.31 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
175,392,892.13 |
| Other Current Liabilities |
2,654,454,156.89 |
| Sub-Total of Current Liabilities |
13,338,024,303.52 |
| Long-term Loans |
-- |
| Bonds Payable |
499,392,566.06 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
640,312.94 |
| Other Non-Current Liabilities |
600,684,444.30 |
| Sub-Total of Non-Current Liabilities |
1,129,693,982.79 |
| Total Liabilities |
14,467,718,286.31 |
| Paid-In Capital(Or Share Stock) |
1,812,816,265.00 |
| Capital Surplus |
3,070,591,048.21 |
| Surplus Reserve |
188,929,981.73 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-992,658,125.67 |
| Minority Stockholder's Interest |
215,015,755.76 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,106,302,371.89 |
| Owner's Equity（Stockholder's Equity） |
4,321,318,127.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
18,789,036,413.96 |
